Urzua, Cristhian2022-06-132022-06-132019Urzua, C., (2019). Vogt Koyanagi Harada Disease. Advances in the Diagnosis and Management of Uveitis. IntechOpen. https://doi.org/10.5772/intechopen.85261https://doi.org/10.5772/intechopen.73886http://hdl.handle.net/11447/6211Vogt-Koyanagi-Harada (VKH) disease is an inflammatory and autoimmune condition characterized by intraocular inflammation, serous retinal detachments, and extraocular manifestations at the level of the auditory, integumentary, and central nervous systems (CNS). No epidemiological studies have been carried out on this condition. However, it has been related to certain geographical areas, such as Latin America and Asia, with a significant contribution of native origin. In this regard, its frequency has been reported up to 22.4% of uveitis causes in referral centers around the world . Recently, significant advances have been reported regarding treatment options and novel approaches to evaluate and categorize this group of patients, in order to personalize follow-up and management in each subject and thus achieve better functional and anatomic outcomesenVogt-Koyanagi-Harada diseaseVKHVitiligoTreatment responseBiomarkersBook chapter